Welcome

Research4Health.Com
Information About Clinical Research in COPD, Asthma, and Allergic Disease

Asthma and Allergy Center of Chicago, SC

Leading Chicago in Community Based Asthma, COPD & Allergic Disease Clinical Research

HAVE YOU TALKED TO SOMEONE ABOUT CLINICAL RESEARCH TODAY?

Over the past two decades, the Asthma and Allergy Center of Chicago has distinguished itself as the leading independent site in Chicago conducting community-based, respiratory disease clinical research. We want you to understand why we conduct clinical research, and what distinguishes us from other clinics and hospitals.  We are defined by:                                                        Our Mission            About Us            Code of Conduct

 ABOUT OUR RESEARCH: FAQ's
 Find A Research Study
   
Here you will find the studies that we are actively seeking participants (you can also check out the table below)

 Questions You Need to Ask
    
Before you participate in clinical research at any site, questions you need to consider.

 Sign-Up for A Study 
 
   
Contact us about participating in our research.  We'll get back to you as soon as possible

 WHAT'S UP: Asthma, Allergy & COPD
    Every now and then, we post some information about what's going on in respiratory medicine

 Asthma & COPD Research Info
    L
inks to various websites with information regarding diagnosis, treatment, and management of Asthma, COPD, and Allergic disease.
 
 Asthma & COPD Research Links
    Links to other clinical trials info, registry for clinical trials

 Our Location
    Directions to our site (or click on the image on the top left side bar)
 

Interested in private patient care and not clinical research? Visit our private practice website: www.AsthmaAllergyChicago.com


One more thing, please help us get the word out about the opportunity to participate in COPD, Asthma, and Allergic disease clinical research here at the Asthma and Allergy Center of Chicago.  You can download flyers and ads at Ads-Flyers to post at your office and freely distribute anywhere you'd like....Questions?  Feel free to CONTACT US
.


                                                 Click Here to Sign-Up For A Study

 DISEASE 
STUDY
 COMMENTS

 

Asthma

A 26-week open-label study to assess the long-term safety of fluticasone propionate multidose dry powder inhaler and fluticasone propionate/salmeterol multidose dry powder inhaler in patients 12 years of age and older with persistent asthma (TEVA 305)


Male / Female Ages >18

Note: this site is not recruiting adolescents  


 Asthma  

A Randomized, Double-Blind, Double Dummy, Parallel Group Study to determine the local equivalence of multiple doses of MGR001 to Advair® Diskus® administered via oral inhalation in adult asthma patients (Mylan Asthma)


Male / Female Ages >18


 

Asthma

A 12 week, double-blind, Placebo-controlled, efficacy and safety study of fluticasone propionate multidose dry powder inhaler compared with fluticasone/salmeterol multidose dry powder inhaler in Adolescent and adult patients with persistent asthma symptomatic despite inhaled corticosteroid therapy (TEVA 30017)


Male / Female > 18

Note: this site is not recruiting adolescents  

                

              Asthma           

 

 A phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of lebrikizumab in adult patients with mild - to -  moderate asthma (STRETTo)

                                    

                    Male / Female > 18                 


COPD 

A Randomised, double-blind, double dummy, chronic dosing (56 week) Placebo-controlled, parallel group, multicenter, phase III study to evaluate the efficacy and safety of 3 doses of Benralizumab (MEDI-563) in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) with a History of COPD exacerbations (TERRANOVA)

  

Male / Female > 40